Notice: This company has been marked as potentially delisted and may not be actively trading. Horizon Therapeutics Public (HZNP) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Horizon Therapeutics Public Lim (HZNP)April 27, 2024 | finance.yahoo.com5 Biotech Acquisition Targets To Accumulate In 2024December 21, 2023 | seekingalpha.comNasdaq On Horizon For Psyence Group: Psilocybin Therapeutics Division Forms New Business CombinationNovember 16, 2023 | msn.comHorizon Therapeutics cut jobs in Deerfield after Amgen acquisitionOctober 24, 2023 | chicago.suntimes.com350 Horizon Therapeutics workers to be laid off, mostly from Deerfield offices, following acquisition by AmgenOctober 24, 2023 | msn.comCongress Asset Management Co. MA Decreases Stake in Horizon Therapeutics Public Limited (NASDAQ:HZNP)Congress Asset Management Co. MA lessened its stake in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 80.4% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 11,645 shares of theOctober 14, 2023 | marketbeat.comTokio Marine Asset Management Co. Ltd. Has $10.94 Million Stock Holdings in Horizon Therapeutics Public Limited (NASDAQ:HZNP)Tokio Marine Asset Management Co. Ltd. cut its holdings in Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 41.9% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 106,400 shares of the biopharmaceuticOctober 13, 2023 | marketbeat.comHorizon Therapeutics Public Limited (NASDAQ:HZNP) Shares Purchased by National Bank of Canada FINational Bank of Canada FI lifted its position in Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 1,042.4% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 219,042 shares of the biopharmacOctober 11, 2023 | marketbeat.comState of Alaska Department of Revenue Sells 23,645 Shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP)State of Alaska Department of Revenue lowered its holdings in Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 36.3% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 41,511 shares of the biopharmaceutical coOctober 10, 2023 | marketbeat.comDekaBank Deutsche Girozentrale Purchases 11,882 Shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP)DekaBank Deutsche Girozentrale increased its position in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 8.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 150,October 9, 2023 | marketbeat.comOlympiad Research LP Has $1.84 Million Position in Horizon Therapeutics Public Limited (NASDAQ:HZNP)Olympiad Research LP raised its holdings in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 30.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 17,857 shares of the biopharmaceuticalOctober 6, 2023 | marketbeat.comRule 17(e) Announcement - Horizon Therapeutics plcOctober 6, 2023 | finance.yahoo.comHorizon Therapeutics Public (NASDAQ:HZNP) Research Coverage Started at StockNews.comStockNews.com started coverage on shares of Horizon Therapeutics Public in a research report on Thursday. They set a "strong-buy" rating on the stock.October 6, 2023 | marketbeat.comTrading was temporarily halted for "HZNP" at 07:10 PM with a stated reason of "News pending."October 6, 2023 | marketbeat.com3 Pharma Stocks With Potential to Outperform Pfizer Inc. (PFE) in OctoberOctober 5, 2023 | stocknews.comRule 17(d) Announcement - Horizon Therapeutics plcOctober 5, 2023 | stockhouse.comRule 17(d) Announcement – Horizon Therapeutics plcOctober 5, 2023 | finance.yahoo.comHorizon Therapeutics Public Limited (NASDAQ:HZNP) Shares Sold by SG Americas Securities LLCSG Americas Securities LLC cut its holdings in Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 96.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,318 shares of the bOctober 4, 2023 | marketbeat.comHorizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023October 2, 2023 | finance.yahoo.comBoard Member at Horizon Therapeutics Exercises Options Worth $2.31MSeptember 26, 2023 | benzinga.comHorizon Therapeutics plc Named to U.S. News & World Report’s 2024 List of Best Companies to Work For in the Health Care IndustrySeptember 26, 2023 | finance.yahoo.comHorizon Therapeutics Public Limited (NASDAQ:HZNP) Shares Sold by Congress Wealth Management LLC DECongress Wealth Management LLC DE reduced its stake in Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 84.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,136 shares of tSeptember 24, 2023 | marketbeat.comPalliser Capital UK Ltd Has $8.17 Million Stake in Horizon Therapeutics Public Limited (NASDAQ:HZNP)Palliser Capital UK Ltd lessened its holdings in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 4.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 79,460 shares of the biopharmaSeptember 21, 2023 | marketbeat.comHorizon Therapeutics plc Ranks Number One on the Fortune Best Workplaces in Biopharma 2023 ListSeptember 19, 2023 | finance.yahoo.comHealth care: FTC Chair Lina Khan to crack down on 'below radar' dealsSeptember 19, 2023 | finance.yahoo.comAtria Wealth Solutions Inc. Sells 2,756 Shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP)Atria Wealth Solutions Inc. trimmed its holdings in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 31.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,998 shares ofSeptember 17, 2023 | marketbeat.comHorizon Therapeutics Public Limited (NASDAQ:HZNP) is Syquant Capital Sas' Largest PositionSyquant Capital Sas grew its holdings in Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 214.1% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 853,166 shares of the biopharmaceutical compSeptember 15, 2023 | marketbeat.comQ32 Bio and Horizon Therapeutics plc Announce Dosing of First Patient in Phase 2 Trial of Bempikibart (formerly ADX-914) for Severe Alopecia AreataSeptember 13, 2023 | finance.yahoo.comHorizon Therapeutics Public (NASDAQ:HZNP) Upgraded by StockNews.com to Strong-BuyStockNews.com raised Horizon Therapeutics Public from a "buy" rating to a "strong-buy" rating in a research note on Wednesday.September 13, 2023 | marketbeat.comHorizon Therapeutics Public Limited (NASDAQ:HZNP) is Governors Lane LP's 2nd Largest PositionGovernors Lane LP grew its holdings in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 193.8% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 451,800 shares of the biopharmaceutical company's stock after purchasing an additionalSeptember 12, 2023 | marketbeat.comRenaissance Technologies LLC Purchases 1,693,400 Shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP)Renaissance Technologies LLC raised its position in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 101.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,368,449 shares of the biopharmaceutSeptember 8, 2023 | marketbeat.comHorizon Therapeutics Public Limited (NASDAQ:HZNP) is Prosight Management LP's 9th Largest PositionProsight Management LP lowered its position in Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 10.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 81,035 shares ofSeptember 7, 2023 | marketbeat.com3 Growth Stocks to Buy in September (HZNP)As the calendar turns to September, optimistic investors will look for value in quality companies with a history of generating strong revenue and earningsSeptember 6, 2023 | marketbeat.comHorizon Therapeutics Announces Date of Irish Court Hearing to Sanction Scheme of ArrangementSeptember 5, 2023 | finance.yahoo.comOxford Financial Group Ltd. Invests $273,000 in Horizon Therapeutics Public Limited (NASDAQ:HZNP)Oxford Financial Group Ltd. bought a new stake in Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 2,500 shares of the biopharmaceuticalSeptember 5, 2023 | marketbeat.comStockNews.com Lowers Horizon Therapeutics Public (NASDAQ:HZNP) to BuyStockNews.com lowered Horizon Therapeutics Public from a "strong-buy" rating to a "buy" rating in a research report on Tuesday.September 5, 2023 | marketbeat.comHere's How Much $1000 Invested In Horizon Therapeutics 10 Years Ago Would Be Worth TodaySeptember 4, 2023 | benzinga.com27,842 Shares in Horizon Therapeutics Public Limited (NASDAQ:HZNP) Purchased by FORA Capital LLCFORA Capital LLC acquired a new position in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 27,842 shares of the biopharmaceutical company's stock,September 3, 2023 | marketbeat.comHorizon Therapeutics plc and Amgen: Amgen and Horizon Therapeutics plc Resolve FTC Lawsuit, Clearing Path to Close AcquisitionSeptember 1, 2023 | finanznachrichten.deAllspring Global Investments Holdings LLC Decreases Stake in Horizon Therapeutics Public Limited (NASDAQ:HZNP)Allspring Global Investments Holdings LLC cut its holdings in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 58.6% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 79,375 shares of the biopharmaceutiSeptember 1, 2023 | marketbeat.comShort Interest in Horizon Therapeutics Public Limited (NASDAQ:HZNP) Decreases By 7.7%Horizon Therapeutics Public Limited (NASDAQ:HZNP - Get Free Report) was the target of a significant drop in short interest in August. As of August 15th, there was short interest totalling 7,860,000 shares, a drop of 7.7% from the July 31st total of 8,520,000 shares. Currently, 3.5% of the company's stock are short sold. Based on an average trading volume of 1,610,000 shares, the short-interest ratio is presently 4.9 days.September 1, 2023 | marketbeat.comHorizon Therapeutics Public (NASDAQ:HZNP) Downgraded to Hold at Jefferies Financial GroupJefferies Financial Group lowered Horizon Therapeutics Public from a "buy" rating to a "hold" rating in a research report on Friday.September 1, 2023 | marketbeat.comHow Much Pain Will Lower Medicare Prices Cause for Pharma Stocks? (HZNP)Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects.September 1, 2023 | marketbeat.comHorizon Therapeutics Public Limited (NASDAQ:HZNP) Given Consensus Recommendation of "Hold" by BrokeragesShares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Get Free Report) have been assigned a consensus recommendation of "Hold" from the seven analysts that are currently covering the company, Marketbeat Ratings reports. Seven research analysts have rated the stock with a hold recommendation.September 1, 2023 | marketbeat.comFTC suspends challenge to Amgen-Horizon Therapeutics dealAugust 28, 2023 | finance.yahoo.comUS FTC suspends challenge to block Amgen's $27.8 bln deal for Horizon TherapeuticsAugust 26, 2023 | reuters.comRamius Advisors LLC Purchases Shares of 141,528 Horizon Therapeutics Public Limited (NASDAQ:HZNP)Ramius Advisors LLC acquired a new stake in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 141,528 shares of the biopharmaceutical company's stock, valued at appAugust 25, 2023 | marketbeat.comHorizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocacy GroupsAugust 23, 2023 | finance.yahoo.comKnott David M Jr Acquires 1,000 Shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP)Knott David M Jr lifted its holdings in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 2.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 41,490 shares of thAugust 23, 2023 | marketbeat.comCredit Suisse AG Has $40.85 Million Position in Horizon Therapeutics Public Limited (NASDAQ:HZNP)Credit Suisse AG boosted its stake in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 3.2% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 374,293 shares of the biopharmaceutical company's stockAugust 22, 2023 | marketbeat.com Get Horizon Therapeutics Public News Delivered to You Automatically Sign up to receive the latest news and ratings for HZNP and its competitors with MarketBeat's FREE daily newsletter. Email Address WARNING: “Buffett Indicator” flashing for first time in 50 years (Ad)Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years. Take these 4 steps today to protect your retirement NOW HZNP Media Mentions By Week HZNP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HZNP News Sentiment▼0.000.60▲Average Medical News Sentiment HZNP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HZNP Articles This Week▼00▲HZNP Articles Average Week Get Horizon Therapeutics Public News Delivered to You Automatically Sign up to receive the latest news and ratings for HZNP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ZTS News RPRX News JAZZ News CORT News PRGO News SUPN News PCRX News OMER News NKTR News ASMB News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HZNP) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Horizon Therapeutics Public Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Horizon Therapeutics Public With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
